tiprankstipranks
Trending News
More News >

Laura A Williams Insider Profile

4 Followers
Laura A Williams, Director at Enliven Therapeutics, holds ― shares in Enliven Therapeutics (Ticker: ELVN), holds 366.32K shares in Ardelyx (Ticker: ARDX). Most recently, Laura A Williams ― shares of Enliven Therapeutics on ― for an estimated value of ―.
tipranks
Laura A Williams

Laura A Williams
Enliven Therapeutics (ELVN)
Director

Ranked #100,490 out of 103,225 Corporate Insiders

Profitable Transactions

20%
2 out of 10 Profitable Transactions

Average Return

-75.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
0.00%
A breakdown of Laura A Williams's holdings

Insider Roles

Ardelyx
(ARDX)
Chief Patient Officer
Enliven Therapeutics
(ELVN)
Director
Roles that Laura A Williams holds in companies

Most Profitable Insider Trade

Stock:
Ardelyx
(ARDX)
Rating:Informative Sell
Date:Jun 07, 2024 - Jun 07, 2025
Return:+42.90%
The most profitable trade made by Laura A Williams

Laura A Williams's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Enliven Therapeutics
Director
Ardelyx
Aug 28, 2025
Chief Patient Officer
Uninformative Buy
49.50K
$2.33M
List of latest transactions for each holding click on a transaction to see Laura A Williams's performance on stock

Laura A Williams insider profile FAQ

What is the percentage of profitable transactions made by Laura A Williams?
The percentage of profitable transactions made by Laura A Williams is 20%.
    What is the average return per transaction made by Laura A Williams?
    The average return per transaction made by Laura A Williams is -75.10%.
      What stocks does Laura A Williams hold?
      Laura A Williams holds: ELVN, ARDX stocks.
        What was Laura A Williams’s latest transaction?
        Laura A Williams latest transaction was an Uninformative Buy of ―.
          What was Laura A Williams's most profitable transaction?
          Laura A Williams’s most profitable transaction was an Informative Sell of ARDX stock on June 7, 2024. The return on the trade was 42.90%.
            What is Laura A Williams's role in Enliven Therapeutics?
            Laura A Williams's role in Enliven Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.